Research News

- Read more about High Intensity Exercise for 10 minutes can better Cardiovascular Health in Teens
Short and high intensity exercise can reduce an adolescent's risk of developing a heart condition, revealed a new study by researcher Alan Barker and his University of Exeter team. The researchers observed that performing eight to ten minutes of high intensity interval exercise thrice a week can improve important markers of cardiovascular health. The study is published in the Journal American Journal of Physiology - Heart and Circulatory Physiology.
- Read more about World's Largest Catalogue of Human Genetic Diversity Created by Scientists
The world's largest catalogue of genomic differences among humans, has been created by an international team of scientists. This catalogue would provide researchers with powerful clues to help them establish why some people are susceptible to various diseases. The findings were detailed in two studies that appeared online in the Nature.
- Read more about Late Night Sleep cause weight Gain
A new study from the University of California, Berkeley has found an association between sleep and body mass index. Teenagers and adults who go to bed late on weeknights are more likely to gain weight than their peers who hit the bed earlier. Moreover, exercise, screen time, and the number of hours they slept did not mitigate this BMI increase, according to the study published in the October issue of the journal, Sleep.
- Read more about FDA permits marketing of new laser-based hearing aid with potential for broad sound amplification
The U.S. Food and Drug Administration allowed marketing of a new hearing aid that uses a laser diode and direct vibration of the eardrum to amplify sound. The combination of laser light pulses and a custom-fit device component that comes in direct contact with the eardrum is designed to use the patient’s own eardrum as a speaker and enables amplification over a wider range of frequencies for some hearing impaired persons. The EarLens Contact Hearing Device (CHD) is indicated for use by adults with mild to severe sensorineural hearing impairment.
- Read more about Stress in Infants Resort to Habits
In adults, previous studies have suggested that stress promotes habits and reduces cognitive flexibility. Psychologists from Germany's Ruhr University Bochum have revealed that the same is true for infants. While under stress, even infants are inclined to resort to habits, rather than try out new things. The findings were published in PNAS.

[adsense:336x280:8701650588]
2 October 2015

Positive Relationship with Siblings reduce Risky Behavior in Adolescence

A new study revealed that Older siblings who had positive relationships with their younger siblings have fewer depressive symptoms and lowest levels of risky behaviors. Overall, the researchers observed that whereas siblings with negative relationships engaged in more risky behaviors. The study appeared in the International Journal of Behavioral Development.
- Read more about NuMedii develop research alliance with Allergan to find new way to treat psoriasis
NuMedii, Inc. announced the formation of a research alliance with Allergan to explore new therapeutic options for the potential treatment of psoriasis. NuMedii has already generated multiple lead compounds/candidates by utilising its data intelligence technology for psoriasis, which will be the focus of the research alliance with Allergan.
- Read more about Scientists developed insulin-producing cells in vivo
A new technique to produce cells with insulin-secretion capabilities has been developed, according to research presented at the 54th Annual European Society for Paediatric Endocrinology Meeting. The technique could be further developed to be used in the transplantation for patients with type 1 diabetes.
- Read more about HIV patients should be included in early clinical trials of anti-TB drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide, yet the majority of these patients are excluded from the early stages in the development of new, anti-tuberculosis drugs, according to findings presented today (29 September, 2015) at the European Respiratory Society's International Congress 2015.
- Read more about Atezolizumab set to change refractory lung cancer treatment
Atezolizumab is set to substantially change treatment strategies for patients with refractory lung cancer, according to Dr Martin Reck, Chief Oncology Physician in the Department of Thoracic Oncology, Hospital Grosshansdorf, Germany. Reck’s comments came as the results from the POPLAR and BIRCH studies showing the first results of efficacy with atezolizumab across lines were presented at the European Cancer Congress 2015 (ECC 2015) in Vienna, Austria.1